查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
精準醫療時代的醫學事務－駕馭複雜性，推動進步：專家問答
市場調查報告書
商品編碼
1726420

精準醫療時代的醫學事務－駕馭複雜性，推動進步：專家問答

Expert Q&A: Medical Affairs in the Precision Medicine Era - Navigating Complexity, Enabling Progress
出版日期: | 出版商: FirstWord Group | 英文 | 商品交期: 最快1-2個工作天內

價格
簡介目錄

醫學事務團隊在精準醫療領域，在彌合尖端科學與臨床實踐之間的差距方面發揮著關鍵作用。他們不僅是數據共享者，還與研究人員和醫療保健專業人員 (HCP) 密切合作，整合基因組學、生物標記和臨床洞察，將複雜的分子數據轉化為服務於不同患者群體的個人化治療策略。

FirstWord 訪問了艾伯維腫瘤全球和美國醫學事務副總裁 Svetlana Kobina，探討了醫學事務在精準醫療中不斷演變的角色、其中蘊含的機會和課題，以及艾伯維如何努力改善患者治療效果。

關鍵問題

  • 精準醫療如何改變了艾伯維醫學事務部門的角色？
  • 管理和分析精準醫療所需的大量資料集面臨的最大課題是什麼？
  • 醫學事務如何促進精準醫療領域研究人員、醫療專業人員 (HCP) 與監管機構之間的合作？
  • 您使用哪些策略有效地將複雜的科學數據傳達給 HCP 和患者？
  • 精準醫療的開發與實施面臨哪些主要的監管課題？
  • 艾伯維 (AbbVie) 如何解決與精準醫療相關的倫理問題，例如可近性和可負擔性？
  • 艾伯維 (AbbVie) 如何確保 HCP 接受適當的培訓，以便在臨床實踐中實施精準醫療？
  • 醫學事務專業人員在臨床醫師的持續教育與訓練中扮演什麼角色？
  • 精準醫療的未來發展方向為何？艾伯維 (AbbVie) 如何為此做好準備？

方法論：

檔案報告是基於獨立而簡潔的分析，這些分析源自於專有的產業研究以及對產業思想領袖的深入訪談。我們的報告深入分析了製藥公司主管需要了解的關鍵發展和市場趨勢，以應對未來的機會和課題。每份報告的重點都基於對二手文獻的回顧和已發現的知識差距。基於這些初步研究，我們制定了基於證據、專家意見的討論指南，以確保我們的研究能夠解答最重要的問題。此外，我們採用嚴格的篩選標準，以確保受訪者有足夠的經驗、知識和資格就該主題發表意見。

我們的報告有何獨特之處？

FirstWord Reports 是值得信賴的行業領導者，專注於製藥業，為生物製藥專業人士和決策者提供深入、可操作的洞察。我們深厚的行業知識使我們能夠為您提供相關且有價值的洞察，幫助您掌握新興趨勢並有效應對複雜課題。憑藉廣泛的研究以及來自領先專家和關鍵意見領袖的獨立、公正的見解，我們的報告能夠為您提供所需的準確性和可靠性。獨家訪談和數據，以及持續的市場監測，讓您可以全面洞察市場動態。我們的報告涵蓋 40 多個活躍疾病領域，包含 KOL 洞察和定量醫生調查等醫生情報，以及行業專家對醫療事務、數位健康、銷售與行銷、市場准入及其他領域問題的看法，助您做出更明智的數據驅動決策，在快速變化的行業中保持競爭力。

簡介目錄

Medical affairs teams are a crucial link between advanced science and clinical practice in precision medicine. Not just data sharers, they integrate genomic, biomarker and clinical insights in close collaboration with researchers and healthcare professionals (HCPs) to translate complex molecular data into personalized treatment strategies to benefit diverse patient populations.

FirstWord spoke with Svetlana Kobina, vice president of oncology global and US medical affairs at AbbVie, about how the role of medical affairs is evolving in precision medicine, the associated opportunities and challenges, and how AbbVie is addressing them to enhance patient outcomes.

Key Questions Answered:

  • How has precision medicine changed the role of medical affairs at AbbVie?
  • What are the biggest challenges in managing and analysing the large datasets required for precision medicine?
  • How does medical affairs facilitate collaboration among researchers, HCPs and regulatory bodies in precision medicine?
  • What strategies do you use to effectively communicate complex scientific data to HCPs and patients?
  • What are the key regulatory challenges in developing and implementing precision medicines?
  • How does AbbVie address ethical concerns related to precision medicine, such as accessibility and affordability?
  • How does AbbVie ensure HCPs are adequately trained to implement precision medicine in clinical practice?
  • What role do medical affairs professionals play in ongoing education and training for clinicians?
  • What future trends do you foresee in precision medicine, and how is AbbVie preparing for them?

Methodology:

Dossier reports are developed from independent and concise analysis derived from original industry surveys and in-depth interviews with industry thought leaders. Reports analyse in detail significant developments and market trends that pharma executives need to understand if they are to manage the opportunities and challenges that lie ahead. The focus of each report is defined by a review of the secondary literature and any knowledge gaps identified. Based on this initial research, an evidence-based and expert-informed discussion guide is developed to ensure the research answers the most critical questions. Additionally, robust screening criteria are established to ensure that those interviewed are qualified in terms of their experience, knowledge and stature to speak on the topic.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.